LC
LLY icon

LCNB Corp’s Eli Lilly LLY Stock Holding History

LCNB Corp’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.87M Buy
2,031
+201
+11% +$204K 0.63% 37
2025
Q4 		$1.97M Buy
1,830
+60
+3% +$57.4K 0.66% 33
2025
Q3 		$1.35M Sell
1,770
-75
-4% -$55.8K 0.47% 47
2025
Q2 		$1.44M Sell
1,845
-23
-1% -$17.9K 0.51% 46
2025
Q1 		$1.54M Sell
1,868
-139
-7% -$116K 0.57% 44
2024
Q4 		$1.55M Sell
2,007
-44
-2% -$36.4K 0.56% 40
2024
Q3 		$1.82M Hold
2,051
– – 0.64% 38
2024
Q2 		$1.86M Sell
2,051
-234
-10% -$187K 0.69% 38
2024
Q1 		$1.78M Hold
2,285
– – 0.64% 41
2023
Q4 		$1.33M Sell
2,285
-46
-2% -$26.9K 0.52% 45
2023
Q3 		$1.25M Sell
2,331
-45
-2% -$23.2K 0.55% 44
2023
Q2 		$1.11M Sell
2,376
-550
-19% -$231K 0.48% 56
2023
Q1 		$1M Sell
2,926
-234
-7% -$78.9K 0.45% 61
2022
Q4 		$1.16M Buy
3,160
+20
+0.6% +$7.09K 0.54% 50
2022
Q3 		$1.01M Hold
3,140
– – 0.55% 47
2022
Q2 		$1.02M Buy
3,140
+665
+27% +$200K 0.53% 53
2022
Q1 		$709K Hold
2,475
– – 0.33% 82
2021
Q4 		$684K Hold
2,475
– – 0.31% 82
2021
Q3 		$572K Sell
2,475
-200
-7% -$49.4K 0.29% 94
2021
Q2 		$614K Buy
2,675
+75
+3% +$15.1K 0.31% 86
2021
Q1 		$486K Sell
2,600
-800
-24% -$156K 0.26% 102
2020
Q4 		$574K Buy
3,400
+17
+0.5% +$2.54K 0.33% 83
2020
Q3 		$501K Sell
3,383
-200
-6% -$31K 0.33% 86
2020
Q2 		$588K Sell
3,583
-75
-2% -$11.5K 0.4% 72
2020
Q1 		$507K Buy
3,658
+459
+14% +$63.1K 0.4% 73
2019
Q4 		$420K Buy
+3,199
New +$371K 0.26% 93

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

LCNB Corp's LLY Position: Q1 2026 in Review

LCNB Corp increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $204K and bringing the position to 2,031 shares worth $1.87M. The position accounts for 0.63% of the portfolio, ranked #37.

LCNB Corp first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.97M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • LCNB Corp held 2,031 shares of Eli Lilly worth $1.87M as of Q1 2026.
  • LCNB Corp bought 201 Eli Lilly shares in Q1 2026, an estimated $204K.
  • Eli Lilly made up 0.63% of LCNB Corp's portfolio in Q1 2026, its #37 holding.
  • LCNB Corp first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • LCNB Corp's Eli Lilly position peaked at $1.97M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on LCNB Corp's 13F filing for Q1 2026, filed 11 May 2026.